Erratum: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development (Cardiovascular Research (2003) 58 (32-45) DOI: 10.1016/S0008-6363(02)00846-5)
Publication
, Journal Article
Redfern, WS; Carlsson, L; Davis, AS; Lynch, WG; MacKenzie, I; Palethorpe, S; Siegl, PKS; Strang, I; Sullivan, AT; Wallis, R; Camm, AJ; Hammond, TG
Published in: Cardiovascular Research
July 1, 2004
Duke Scholars
Published In
Cardiovascular Research
DOI
ISSN
0008-6363
Publication Date
July 1, 2004
Volume
63
Issue
1
Start / End Page
186 / 187
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Redfern, W. S., Carlsson, L., Davis, A. S., Lynch, W. G., MacKenzie, I., Palethorpe, S., … Hammond, T. G. (2004). Erratum: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development (Cardiovascular Research (2003) 58 (32-45) DOI: 10.1016/S0008-6363(02)00846-5). Cardiovascular Research, 63(1), 186–187. https://doi.org/10.1016/j.cardiores.2004.04.016
Redfern, W. S., L. Carlsson, A. S. Davis, W. G. Lynch, I. MacKenzie, S. Palethorpe, P. K. S. Siegl, et al. “Erratum: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development (Cardiovascular Research (2003) 58 (32-45) DOI: 10.1016/S0008-6363(02)00846-5).” Cardiovascular Research 63, no. 1 (July 1, 2004): 186–87. https://doi.org/10.1016/j.cardiores.2004.04.016.
Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, et al. Erratum: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development (Cardiovascular Research (2003) 58 (32-45) DOI: 10.1016/S0008-6363(02)00846-5). Cardiovascular Research. 2004 Jul 1;63(1):186–7.
Redfern, W. S., et al. “Erratum: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development (Cardiovascular Research (2003) 58 (32-45) DOI: 10.1016/S0008-6363(02)00846-5).” Cardiovascular Research, vol. 63, no. 1, July 2004, pp. 186–87. Scopus, doi:10.1016/j.cardiores.2004.04.016.
Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PKS, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG. Erratum: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development (Cardiovascular Research (2003) 58 (32-45) DOI: 10.1016/S0008-6363(02)00846-5). Cardiovascular Research. 2004 Jul 1;63(1):186–187.
Published In
Cardiovascular Research
DOI
ISSN
0008-6363
Publication Date
July 1, 2004
Volume
63
Issue
1
Start / End Page
186 / 187
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology